ArticlePharmacoEconomics2010

Cost effectiveness of intensive lipid-lowering treatment for patients with congestive heart failure and coronary heart disease in the US.

Virginia M Rosen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.